HA Baba

Activation of extracellular regulated kinases (ERK1/2) but not AKT predicts poor prognosis in colorectal carcinoma and is associated with k-ras mutations

Klaus J. Schmitz, Jeremias Wohlschlaeger, Hakan Alakus et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2006 · 59 citations

Medicine, Cancer Biology, Oncology +16

Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways

Klaus J. Schmitz, R. Callies, Jeremias Wohlschlaeger et al. · Journal of Clinical Pathology · 2006 · 36 citations · Full text

Medicine, Cancer Biology, Oncology +15

Suppression of Panel-Reactive Antibodies by Treatment with Mycophenolate Mofetil

Christina Schmid, Henk Garritsen, Reinhard Kelsch et al. · The Thoracic and Cardiovascular Surgeon · 1998 · 25 citations

Medicine, Cardiology, Pharmacology +17

Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.

Georgios C. Sotiropoulos, M Malagò, Ernesto P. Molmenti et al. · PubMed · 2005 · 25 citations

Medicine, Oncology, Surgery +17

Cyclo-oxygenase-2 overexpression is a feature of early and well-differentiated hepatocellular carcinoma with a favourable prognosis

Klaus J. Schmitz, Jeremias Wohlschlaeger, Hauke Lang et al. · Journal of Clinical Pathology · 2009 · 18 citations

Medicine, Oncology, Pathology +14